Okay. Deep breath. If somebody told you retatrutide is "going away on September 24," I want you to set that down for just a second. Not because I'm going to tell you everything is fine, and not because I'm going to tell you everything is doomed — but because right now there is a LOT of information flying around, and a good chunk of it is just... wrong. So I'm starting a series. We're going to follow this retatrutide story from the very beginning, all the way through September 24, and whatever happens after that. In plain English. No rumors, no fear-mongering, no picking sides. Just one question, over and over: what do the actual documents say? Let's start by killing the biggest rumor. September 24, 2026 is NOT the day retatrutide gets banned. It is also NOT the day retatrutide magically becomes FDA approved. I know. Both of those have been floating around. Neither one is true. So what actually IS happening that day? On September 24, lawyers for Eli Lilly and lawyers for the federal government are scheduled to show up in front of a federal appeals court. If "appeals court" makes your eyes glaze over, stay with me, because it's honestly simpler than it sounds. Picture two people who disagree about what a rule means. They take it to a judge. The judge makes a call. And then one side goes, "Hold on — we think the judge got part of that wrong, and we want a higher court to look at it." That's an appeal. That's it. That's the whole thing. So on September 24, the lawyers walk into the U.S. Court of Appeals for the Seventh Circuit and make their case out loud to a panel of judges. That's called oral argument. And here's the part I really want you to hang onto: September 24 is the day both sides go in and explain their positions. It is not necessarily the day we get an answer. Those judges can listen, ask a hundred questions, go back and study the whole thing, and then release their written decision weeks or months later. Courts do not work on Instagram timelines. 😅